RxDoctor Payments Data

Diana Soulias, MD

Family Medicine · Farmington Hills, MINPI 1962462887

Payments from drug & device makers

$4,905in general payments, 2019–2025

Across 285 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$564
  • AstraZeneca$452
  • GSK$414
  • Pfizer$317
  • Lilly USA, LLC$305
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,79498%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,905 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$85,794
Medicare patients
185
Services billed
2,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$47,844
EliquisApixaban51$41,154
TrulicityDulaglutide30$33,993
JanuviaSitagliptin Phosphate25$24,509
MyrbetriqMirabegron14$16,224
Breo ElliptaFluticasone/Vilanterol16$11,486
Levothyroxine Sodium338$5,218
Atorvastatin Calcium357$4,815
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,882
Losartan Potassium238$2,675
Simvastatin225$2,438
Metoprolol Succinate125$2,222
Pantoprazole Sodium107$2,066
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide64$1,531
Lisinopril167$1,478

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,009$47,84429 claims
PfizerEliquis$317$41,15451 claims
Lilly USA, LLCTrulicity$305$33,99330 claims
MerckJanuvia$196$24,50925 claims
Astellas Pharma US IncMyrbetriq$141$16,22414 claims
GSKBreo Ellipta, Shingrix$414$14,36829 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$98$5,218338 claims
AbbVieSynthroid$179$1,29931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Farmington Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →